Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit

The treatment effect in survival analysis is commonly quantified as the hazard ratio, and tested statistically using the standard log-rank test. Modern anticancer immunotherapies are successful in a proportion of patients who remain alive even after a long-term follow-up. This new phenomenon induces...

Celý popis

Podrobná bibliografia

Vydané v:	JNCI : Journal of the National Cancer Institute Ročník 111; číslo 11; s. 1186
Hlavní autori:	Péron, Julien, Lambert, Alexandre, Munier, Stephane, Ozenne, Brice, Giai, Joris, Roy, Pascal, Dalle, Stéphane, Machingura, Abigirl, Maucort-Boulch, Delphine, Buyse, Marc
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.11.2019
ISSN:	1460-2105, 1460-2105
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!